CSIMarket
 


Mateon Therapeutics Inc  (OXGN)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare

Mateon Therapeutics Inc's Working Capital Ratio

OXGN's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




OXGN Working Capital Ratio (Jun 30 2019)
II. Quarter
(Sep 30 2018)
III. Quarter
(Jun 30 2018)
II. Quarter
(Mar 31 2018)
I. Quarter
(Dec 31 2017)
IV. Quarter
Y / Y Current Liabilities Change 79.24 % -12.11 % 9.81 % 7.74 % -26.45 %
Y / Y Current Assets Change -83.36 % -60.89 % -68.17 % -96.01 % -91.92 %
Working Capital Ratio MRQ 0.09 1.16 1.44 0.28 1
Overall Ranking # 4171 # # 1 # 3659 # 3205
Seq. Current Liabilities Change 107.02 % -31.12 % -0.07 % 25.79 % 1.51 %
Seq. Current Assets Change -83.53 % -44.39 % 411.39 % -64.47 % -61.3 %



Working Capital Ratio second quarter 2019 Comment
Due to increase in Current Liabilities in the second quarter 2019, Working Capital Ratio fell to 0.09 below Mateon Therapeutics Inc average.

Within Biotechnology & Drugs industry 182 other companies have achieved higher Working Capital Ratio than Mateon Therapeutics Inc in second quarter 2019. While Working Capital Ratio total ranking has deteriorated compare to previous quarter from to 4171.

Explain Working Capital Ratio
Where is OXGN most successful ?
Working Capital Ratio OXGN on the trailing twelve month basis
Working Capital Ratio second quarter 2019 Company Ranking
Within: No.
Biotechnology & Drugs Industry # 183
Healthcare Sector # 714
Overall Market # 4170


Working Capital Ratio Statistics
High Average Low
45.33 12.89 0.09
(Mar 31 2015)   (Jun 30 2019)




Financial Statements
Mateon Therapeutics Inc's Current Liabilities $ 2 Millions Visit OXGN's Balance sheet
Mateon Therapeutics Inc's Current Assets $ 0 Millions Visit OXGN's Balance sheet
Source of OXGN's Sales Visit OXGN's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingJun 30 2019, within Biotechnology & Drugs Industry Working Capital RatioJun 30 2019 MRQ Current AssetsJun 30 2019 MRQ Current Liabilities
Artemis Therapeutics, Inc.  0.25 $ 0.038  Millions$ 0.154  Millions
American Cryostem Corp  0.24 $ 0.295  Millions$ 1.252  Millions
Gtx Corp  0.23 $ 0.983  Millions$ 4.224  Millions
Cytodyn Inc.  0.20 $ 5.369  Millions$ 26.926  Millions
Q Biomed Inc.  0.16 $ 0.207  Millions$ 1.292  Millions
Biorestorative Therapies, Inc.  0.12 $ 1.357  Millions$ 11.143  Millions
Quest Patent Research Corp  0.09 $ 0.705  Millions$ 7.439  Millions
Mateon Therapeutics Inc  0.09 $ 0.189  Millions$ 2.043  Millions
Therapeutic Solutions International, Inc.  0.09 $ 0.170  Millions$ 1.851  Millions
U.s. Stem Cell, Inc.  0.09 $ 0.682  Millions$ 7.826  Millions
Petvivo Holdings, Inc.  0.08 $ 0.128  Millions$ 1.514  Millions
Cannapharmarx, Inc.  0.07 $ 0.132  Millions$ 1.773  Millions
Boston Therapeutics, Inc.  0.07 $ 0.381  Millions$ 5.462  Millions
Premier Biomedical Inc  0.06 $ 0.147  Millions$ 2.299  Millions
Burzynski Research Institute Inc  0.06 $ 0.013  Millions$ 0.213  Millions
Entest Group, Inc.  0.04 $ 0.001  Millions$ 0.027  Millions
Endonovo Therapeutics, Inc.  0.03 $ 0.586  Millions$ 20.214  Millions
Respirerx Pharmaceuticals Inc.  0.02 $ 0.150  Millions$ 6.767  Millions
Mount Tam Biotechnologies, Inc.  0.02 $ 0.059  Millions$ 2.661  Millions


             
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

FEPI's Profile

Stock Price

FEPI's Financials

Business Description

Fundamentals

Charts & Quotes

FEPI's News

Suppliers

FEPI's Competitors

Customers & Markets

Economic Indicators

FEPI's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2019 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071